Open AccessClenbuterol-Induced Myocarditis: A Case Report
Author(s) -
Natassja Moriarty,
Nadeem Attar
Publication year - 2020
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2020_001662
Subject(s) - clenbuterol , medicine , discontinuation , myocarditis , adverse effect , intensive care medicine , surgery , pharmacology
Objective: We present a case of a 22-year-old bodybuilder diagnosed with myocarditis secondary to clenbuterol use. Results: The patient was primarily managed conservatively by the discontinuation of clenbuterol and the temporary use of dual anti-platelets, beta-blockers and nitrates. Conclusion: Clenbuterol is a long-acting beta-2 agonist primarily used in veterinary medicine. In recent years, it has been illegally marketed as a weight loss supplement because of its anabolic properties and is popular among fitness enthusiasts. It is our aim to use this case to underscore the adverse effects of this drug with hopes that tighter regulations will be instituted to stem its illegal distribution.